FDA Orange Book
Generic for Carnitor SF
Carnitor SF contains levocarnitine. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
Yes. The generic name for Carnitor SF is levocarnitine. 3 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AA.
Run it in Rivvi
Map Carnitor SF and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Carnitor SF products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| solution, oral | 1GM/10ML | Marketed (Rx) | AA | 4 | AA |
NDA 019257, held by LEADIANT BIOSCIENCES INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Approved generic levocarnitine
| Company | ANDA | TE code | Approved | Strengths |
|---|---|---|---|---|
| RISING PHARMA HOLDINGS INC | 076851 | AA (A-rated, therapeutically equivalent) | August 10, 2004 | 1GM/10ML |
| NOVITIUM PHARMA LLC | 211676 | AA (A-rated, therapeutically equivalent) | August 14, 2019 | 1GM/10ML, 1GM/10ML |
| SCIEGEN PHARMACEUTICALS INC | 212533 | AA (A-rated, therapeutically equivalent) | November 10, 2021 | 1GM/10ML |
Carnitor SF NDC codes
Questions
Is there a generic for Carnitor SF?
Yes. The generic name for Carnitor SF is levocarnitine. 3 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AA.
What is the generic name for Carnitor SF?
The active ingredient in Carnitor SF is levocarnitine, per the FDA Orange Book.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.